Hits & Myths: Is it OK to allow asthmatic children to play sport? – South China Morning Post

Hits & Myths: Is it OK to allow asthmatic children to play sport?
South China Morning Post
Is it okay for kids with asthma to play sports? The straight answer: Yes. The facts: It's perfectly fine for asthmatic children to take up sports. In fact, many elite and Olympic athletes are asthmatic, like British marathon runner Paula Radcliffe and

View full post on asthma – Google News

Cytos hits the self-destruct button as PhIIb asthma study bombs – FierceBiotech

Cytos hits the self-destruct button as PhIIb asthma study bombs
FierceBiotech
The Swiss biotech said that its asthma drug CYT003 flunked its primary as well as secondary endpoints in the critically important study, making it all but impossible to raise more funds for the company. As a result, CEO Christian Itin has hit the self
Cytos Begins Layoff Process, Eyes Liquidation After Phase IIb FailureGenetic Engineering News
Cytos considering options to wind down companyReuters

all 5 news articles »

View full post on asthma – Google News

Prospect of generic asthma drug Advair hits Glaxo – Philly.com


The West Australian

Prospect of generic asthma drug Advair hits Glaxo
Philly.com
GlaxoSmithKline P.L.C.'s top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue, but generic competition got a bit closer to reality this week. Advair is delivered to patients through an inhaler
Mylan shares jump after FDA lays out guidelines for asthma genericMarketWatch (blog)
FDA Offers Guidance for Advair KnockoffsWall Street Journal
Glaxo May Face Generic Advair Sooner Than ExpectedForbes
Chicago Tribune –PMLiVE –FiercePharma
all 24 news articles »

View full post on asthma – Google News

Rigel drops asthma drug after trial fails, stock hits life-low – Reuters


The Denver Channel

Rigel drops asthma drug after trial fails, stock hits life-low
Reuters
(Reuters) – Rigel Pharmaceuticals Inc said it will stop developing its experimental asthma drug after the therapy failed in a mid-stage trial, sending its shares down as much as 17 percent to a life-low. The failure of the inhaled drug is the latest
Rigel Shares Plunge After Asthma Drug Fails to Meet GoalsBloomberg
Rigel shares slide after another drug flops in PhII asthma studyFierceBiotech
Rigel Pharmaceuticals skids after asthma drug fails in studyThe Denver Channel
Wall Street Journal –PR Newswire (press release) –NASDAQ
all 30 news articles »

View full post on asthma – Google News

Glenmark hits 52-week high on US nod for asthma generic drug – Business Today


Business Today

Glenmark hits 52-week high on US nod for asthma generic drug
Business Today
Shares of Glenmark Pharma hit a fresh 52-week high on Monday after the company received approval from the US health regulator to manufacture and market generic montelukast sodium tablets used for treating asthma and allergies . Glenmark said it would

and more »

View full post on asthma – Google News